(19)
(11) EP 4 816 393 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24826866.6

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/39591; C07K 2317/94; C07K 2317/31; C07K 16/283; C07K 16/2878; C07K 16/468; C07K 2317/62; C07K 2317/64; C07K 2317/626
(86) International application number:
PCT/EP2024/084034
(87) International publication number:
WO 2025/114503 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 EP 23212923

(71) Applicant: Affimed GmbH
68165 Mannheim (DE)

(72) Inventors:
  • WALL, Claudia
    68165 Mannheim (DE)
  • WEICHEL, Michael
    68165 Mannheim (DE)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) FORMULATION FOR ANTIBODY CONSTRUCTS